Drug Development Solution Services
At RoukenBio, we provide end-to-end drug development services designed to accelerate innovation in immunology, immuno-oncology, and immune-mediated disease. Our expertise in preclinical drug development enables innovative biotechnology companies to generate the functional, mechanistic, and safety data needed to move confidently from discovery to IND submission.
Our consultative and collaborative approach allows us to tackle challenging, complex projects for a global customer base, delivering excellence across various drug modalities and therapeutic fields. We provide industry-leading pre-established methodologies, alongside novel platforms like IndEx-2 or a completely custom approach designed for your specific therapeutic requirements.
Comprehensive Support Across Every Development Phase up to IND submission
From validating a novel target, characterising a biologic, or assessing immune safety profiles, our drug development solutions are built on scientific insight, collaborative partnership, and uncompromising data quality.
Explore our core drug development solution areas:
Phase
At RoukenBio, we provide comprehensive non-regulatory support across all phases of drug development. We help you design the right assays generating quality data that aid and support faster and more precise decision-making so your candidate can reach the clinic.
Therapeutic Antibody Development and Modalities
Our multidisciplinary team of experts is dedicated to supporting the development of various therapeutic modalities, each with its own unique challenges and opportunities. We tailor our assays and models to fit your molecule type and mechanism of action.
Therapeutic Focus
Our expertise spans across a diverse range of therapeutic fields, making us a premier partner for the development of innovative therapies across oncology, immuno-oncology, autoimmunity, allergy, inflammation, infectious disease and beyond.
FAQs
As a pre-clinical immunology CRO and comprehensive solutions provider, we cover the full spectrum of discovery to pre-IND testing including:
- Target biology validation
- Lead selection
- Lead optimisation and characterisation
- Product characterisation
We have a strong foundation in biotherapeutics including biologics (e.g. antibody and protein/peptide-based molecules) and cell-based therapies. However, we are modality agnostic and can functionally characterise any immunotherapy.
In addition to enabling drug discovery of novel therapeutic candidates, we provide extensive analytical biosimilarity services for the characterisation of biosimilars.
Our specialised CRO services redefine the traditional drug discovery process, acting as an external partner; we create custom approaches and develop novel, innovative technologies, like our IndEx-2 platform, driving real innovation across the full drug discovery process.
Propel drug discovery breakthroughs with RoukenBio
Difficulty doesn’t deter us; it inspires us. Give us a problem, and we’ll find your solution. Our versatile specialists embrace every obstacle as an opportunity to showcase our innovative thinking and problem-solving prowess.
Access our Capabilities brochure
